# Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke

> **NCT01518231** · PHASE1 · UNKNOWN · sponsor: **Zhejiang Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Stroke

## Interventions

- **PROCEDURE:** autologous hematopoiesis stem cell transplantation
- **DRUG:** Aspirin
- **DRUG:** Warfarin
- **DRUG:** Atorvastatin
- **DRUG:** Edaravone
- **DRUG:** Aspirin
- **DRUG:** Warfarin
- **DRUG:** Atorvastatin
- **DRUG:** Edaravone

## Key facts

- **NCT ID:** NCT01518231
- **Lead sponsor:** Zhejiang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2012-12
- **Final completion:** 2013-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2012-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01518231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01518231, "Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01518231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*